{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:05:30Z","timestamp":1774278330092,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00198-012-1984-z","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T08:01:51Z","timestamp":1337068911000},"page":"511-521","source":"Crossref","is-referenced-by-count":66,"title":["Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan"],"prefix":"10.1007","volume":"24","author":[{"given":"Y.-K.","family":"Soong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-S.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-Y.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.-S.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.-H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-E.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"key":"1984_CR1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00198-004-1651-0","volume":"15","author":"WC Chie","year":"2004","unstructured":"Chie WC, Yang RS, Liu JP, Tsai KS (2004) High incidence rate of hip fracture in Taiwan: estimated from a Nationwide Health Insurance database. Osteoporos Int 15:998\u20131002","journal-title":"Osteoporos Int"},{"key":"1984_CR2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","volume":"359","author":"PD Delmas","year":"2002","unstructured":"Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359:2018\u20132026","journal-title":"Lancet"},{"issue":"Suppl 3","key":"1984_CR3","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1007\/BF03194352","volume":"7","author":"KS Tsai","year":"1997","unstructured":"Tsai KS, Tai TY (1997) Epidemiology of osteoporosis in Taiwan. Osteoporos Int 7(Suppl 3):S96\u2013S98","journal-title":"Osteoporos Int"},{"key":"1984_CR4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513\u2013521","journal-title":"JAMA"},{"key":"1984_CR5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 285:785\u2013795","journal-title":"JAMA"},{"key":"1984_CR6","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/S0002-9343(97)90022-X","volume":"103","author":"C Cooper","year":"1997","unstructured":"Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S\u201317S, discussion 17S\u201319S","journal-title":"Am J Med"},{"key":"1984_CR7","first-page":"193","volume":"79","author":"MG Sweet","year":"2009","unstructured":"Sweet MG, Sweet JM, Jeremiah MP, Galazka SS (2009) Diagnosis and treatment of osteoporosis. Am Fam Physician 79:193\u2013200","journal-title":"Am Fam Physician"},{"key":"1984_CR8","unstructured":"Association T.T.O. (2007) Osteoporosis treatment guideline. http:\/\/www.toa1997.org.tw . Accessed May 12 2009"},{"key":"1984_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.healthpol.2005.04.009","volume":"75","author":"NP Yang","year":"2006","unstructured":"Yang NP, Deng CY, Chou YJ, Chen PQ, Lin CH, Chou P, Chang HJ (2006) Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 75:329\u2013337","journal-title":"Health Policy"},{"key":"1984_CR10","first-page":"806","volume":"96","author":"SN Chow","year":"1997","unstructured":"Chow SN, Huang CC, Lee YT (1997) Demographic characteristics and medical aspects of menopausal women in Taiwan. J Formos Med Assoc 96:806\u2013811","journal-title":"J Formos Med Assoc"},{"key":"1984_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","volume":"49","author":"R Graham","year":"2011","unstructured":"Graham R, Russell G (2011) Bisphosphonates: The first 40\u00a0years. Bone 49:2\u201319","journal-title":"Bone"},{"key":"1984_CR12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1359\/jbmr.080510","volume":"23","author":"AM Gallagher","year":"2008","unstructured":"Gallagher AM, Rietbrock S, Olson M, van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569\u20131575","journal-title":"J Bone Miner Res"},{"key":"1984_CR13","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","volume":"165","author":"DH Solomon","year":"2005","unstructured":"Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414\u20132419","journal-title":"Arch Intern Med"},{"key":"1984_CR14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022","journal-title":"Mayo Clin Proc"},{"key":"1984_CR15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","volume":"80","author":"RR Recker","year":"2005","unstructured":"Recker RR, Gallagher R, MacCosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856\u2013861","journal-title":"Mayo Clin Proc"},{"key":"1984_CR16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","volume":"15","author":"JJ Caro","year":"2004","unstructured":"Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15:1003\u20131008","journal-title":"Osteoporos Int"},{"key":"1984_CR17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00198-006-0179-x","volume":"17","author":"D Weycker","year":"2006","unstructured":"Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17:1645\u20131652","journal-title":"Osteoporos Int"},{"key":"1984_CR18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1185\/030079906X167615","volume":"23","author":"DT Gold","year":"2007","unstructured":"Gold DT, Martin BC, Frytak JR, Amonkar MM, Cosman F (2007) A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis. Curr Med Res Opin 23:585\u2013594","journal-title":"Curr Med Res Opin"},{"key":"1984_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-007-0466-1","volume":"19","author":"FJ Penning-van Beest","year":"2008","unstructured":"Penning-van Beest FJ, Erkens JA, Olson M, Herings RM (2008) Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteoporos Int 19:511\u2013517","journal-title":"Osteoporos Int"},{"key":"1984_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2008.09.004","volume":"44","author":"CJ Shao","year":"2009","unstructured":"Shao CJ, Hsieh YH, Tsai CH, Lai KA (2009) A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone 44:125\u2013129","journal-title":"Bone"},{"key":"1984_CR21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bone.2006.12.063","volume":"40","author":"T Chevalley","year":"2007","unstructured":"Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991\u20132000): reversal of a secular trend. Bone 40:1284\u20131289","journal-title":"Bone"},{"key":"1984_CR22","doi-asserted-by":"crossref","unstructured":"Finsen V, Johnsen LG, Trano G, Hansen B, Sneve KS (2004) Hip fracture incidence in central Norway: a followup study. Clin Orthop Relat Res 173\u2013178","DOI":"10.1097\/00003086-200402000-00028"},{"key":"1984_CR23","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-005-1974-5","volume":"16","author":"H Hagino","year":"2005","unstructured":"Hagino H, Katagiri H, Okano T, Yamamoto K, Teshima R (2005) Increasing incidence of hip fracture in Tottori Prefecture, Japan: trend from 1986 to 2001. Osteoporos Int 16:1963\u20131968","journal-title":"Osteoporos Int"},{"key":"1984_CR24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00198-009-0925-y","volume":"20","author":"Y Wang","year":"2009","unstructured":"Wang Y, Tao Y, Hyman ME, Li J, Chen Y (2009) Osteoporosis in China. Osteoporos Int 20:1651\u20131662","journal-title":"Osteoporos Int"},{"key":"1984_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/pubmed\/21.3.249","volume":"21","author":"EM Lau","year":"1999","unstructured":"Lau EM, Cooper C, Fung H, Lam D, Tsang KK (1999) Hip fracture in Hong Kong over the last decade\u2013a comparison with the UK. J Public Health Med 21:249\u2013250","journal-title":"J Public Health Med"},{"key":"1984_CR26","first-page":"449","volume":"11","author":"R Sikka","year":"2005","unstructured":"Sikka R, Xia F, Aubert RE (2005) Estimating medication persistency using administrative claims data. Am J Manag Care 11:449\u2013457","journal-title":"Am J Manag Care"},{"key":"1984_CR27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00198-008-0829-2","volume":"20","author":"O Sheehy","year":"2009","unstructured":"Sheehy O, Kindundu C, Barbeau M, LeLorier J (2009) Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures. Osteoporos Int 20:1583\u20131594","journal-title":"Osteoporos Int"},{"key":"1984_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2474-8-97","volume":"8","author":"J Adachi","year":"2007","unstructured":"Adachi J, Lynch N, Middelhoven H, Hunjan M, Cowell W (2007) The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review. BMC Musculoskelet Disord 8:97","journal-title":"BMC Musculoskelet Disord"},{"key":"1984_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/dc07-1072","volume":"31","author":"HF Chen","year":"2008","unstructured":"Chen HF, Ho CA, Li CY (2008) Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study. Diabetes Care 31:75\u201380","journal-title":"Diabetes Care"},{"key":"1984_CR30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","volume":"21","author":"JA Cramer","year":"2005","unstructured":"Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21:1453\u20131460","journal-title":"Curr Med Res Opin"},{"key":"1984_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287:337\u2013344","journal-title":"JAMA"},{"key":"1984_CR32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00198-006-0166-2","volume":"17","author":"AJ Carr","year":"2006","unstructured":"Carr AJ, Thompson PW, Cooper C (2006) Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int 17:1638\u20131644","journal-title":"Osteoporos Int"},{"key":"1984_CR33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00198-006-0073-6","volume":"17","author":"M Rossini","year":"2006","unstructured":"Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914\u2013921","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-1984-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-1984-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-1984-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:45Z","timestamp":1558624125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-1984-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-1984-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,16]]}}}